Approved the Unaudited Financial Results of the Company for the quarter ended on June 30, 2025 and took on record Limited Review Report thereon.
RELCHEMQ · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The Board of Reliance Chemotex Industries approved unaudited financial results for Q1 FY26 (quarter ended June 30, 2025), which have been reviewed by auditors PKMB & Co. with an unmodified limited review report. Revenue from operations was largely flat YoY at Rs. 9,236.37 lakh versus Rs. 9,256.52 lakh in Q1 FY25, while total income fell to Rs. 9,275.42 lakh from Rs. 9,669.45 lakh due to sharply lower other income. Net profit, however, jumped nearly 81% YoY to Rs. 106.33 lakh from Rs. 58.76 lakh, helped by lower raw material and other expenses. Profit before tax rose to Rs. 95.51 lakh from Rs. 17.25 lakh, with the company continuing to operate in a single segment (Yarns). The trading window for designated persons remains closed till August 16, 2025.
Flat top line but a sharp rise in net profit and operating margins signals improving operational efficiency, which is mildly positive for shareholders, though the heavy finance cost (~Rs. 650 lakh) continues to weigh on profitability.